USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Rescon Ltd

USPTO PatentsView assignee record - 12 granted patents across 8 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Rescon ranks #23,286 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 8 technology areas.

#23,286
of 49,997 US assignees by volume
33rd percentile
by Innovation Score (30.2/100)
18.8
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23286 · Foreign Corporation #23,286 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 12 grants
  • MID-PACK #23,286/49,997
  • PHOTO-FINISH Rehab2fit
  • CPC-NARROW A61B · 8 areas
  • INNOV-THIN 30.2/100
  • CLAIMS-RICH 18.8 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Rehab2fit Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rescon’s 30.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Rescon

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Rescon's Innovation Score is 30.2/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Rescon?

Each dot is one of Rescon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rescon’s own 18.8 claims/patent is ABOVE the 17.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Rescon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 11.911.91212.1 010203040 Granted patents (volume) Avg claims / patent Rehab2fit Technologies, Inc. - 12, 17.58Rehab2fitReichert, Inc. - 12, 10.83ReichertReichle & De-massari AG - 12, 18.83Reichle & De-mass…Rentokil Initial 1927 PLC - 12, 6.75Rentokil Initial…Resilient Power Systems, Inc. - 12, 20Resilient Power S…Resuscitec GMBH - 12, 33.92ResuscitecRexahn Pharmaceuticals, Inc. - 12, 19.17Rexahn Pharmaceut…Rhodia Acetow GMBH - 12, 17.25Rhodia AcetowRescon Ltd - 12, 18.83Rescon
Rescon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rescon's grants concentrate

Rescon Ltd is a focused PatentsView assignee: 8 CPC subclasses with 75% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2019. By volume, Rescon sits between Rehab2fit Technologies, Inc. and Rhodia Acetow GMBH.

Who files at Rescon's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Rescon holds 12 patents at rank #23,267, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Rescon

By rank, the assignees closest to #23,267 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Rescon's primary technology class.

Rescon's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 33rd percentile higher than 33% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 2015201620172019 1
USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Rescon Ltd patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 25.0%
2016 5 41.7%
2017 3 25.0%
2019 1 8.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Rescon Ltd's patent record in context - here's where to go next.

  • Rescon Ltd's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 75% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #23,286 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Rescon Ltd against Rehab2fit Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 30.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.